The new study, 'The cost of stroke and transient ischaemic attack in Ireland – a prevalence-based estimate', funded by the Irish Heart Foundation, is a prevalence-based study examining the total costs of stroke and transient ischaemic attack (TIA) in Ireland in 2007, aggregating the cost of those living with the consequences of stroke and those experiencing a stroke. The study looks at costs incurred by the national government, private health organizations, and individuals.
Ireland offers an interesting context to examine stroke care as until recently, stroke services remained relatively underdeveloped and, like the health services more generally, contain a complex mix of public and private provisions. There had also been very little national service coordination of stroke and TIA services until now. The first National Audit of Stroke Care (INASC) highlighted substantial deficits in primary and secondary prevention, hospital treatment, rehabilitation, and other services.
The economic burden of stroke and TIA in Ireland in 2007 is estimated to have been €500-€816 million. Direct expenditure on stroke accounts for 2-4% of total health expenditure and 0.2-0.3% GNP in Ireland, which amounts to €345-€557million in total. 79% of direct stroke expenditure is publicly funded with out-of-pocket payments accounting for 19% of the total, and 3% from private health insurance funding.
Nursing home care and indirect costs accounts for more than 70% of total stroke costs in Ireland, highlighting the chronic phase of stroke care as the most important factor in total stroke costs. Nursing home care accounts for a higher proportion of direct costs in Ireland relative to other studies. This may reflect the fact that while effective treatments are available to reduce acute stroke morbidity and mortality, these services are not universally provided in Ireland. The national audit of patients receiving acute care in 2005 found that less than 2% of stroke cases were treated in a stroke unit and 1% received thrombolysis.
This study is the first to provide a detailed analysis of total direct and indirect annual stroke and TIA costs using Irish-specific data. The Irish perspective does suggest that current nursing home costs are higher than they might otherwise be if more timely acute care reduced the level of disability in stroke survivors and associated need for long-term care.
Samantha Smith, joint author of the paper and Post-Doctoral Fellow at the Economic & Social Research Institute, said: "This type of study highlights the economic burden imposed by the chronic phase of stroke disease and the support from the Irish Heart Foundation in funding this study is very much appreciated. Acute stroke unit care is known to be cost effective and all acute stroke patients can benefit from care in these units with lower risks of death and disability. Stroke thrombolysis, for suitable cases, reduces disability and is also known to be cost effective. Enhanced provision of these evidence-based treatments for stroke in Ireland is now ongoing, supported by Government via the Health Service Executive. It would be expected that the associated reduced level of disability in stroke survivors in Ireland would give rise to a reduction in the need for long-term care and associated long-term care costs."
Information on the prevalence-based costs of different illnesses can inform health policy makers when setting priorities, evaluating existing services, allocating resources and planning new services. This paper adds to the available evidence on the economic burden of stroke and transient ischaemic attach (TIA) and suggests areas where further analysis is needed to unpick the reasons behind the estimated costs in order to inform policy appropriately.
Total cost of stroke and TIA in Ireland is estimated to have been €500–€816 million in 2007.
The total cost of stroke comprised €345–€557 million in direct costs and €143–€248 million in indirect costs.
The chronic phase of the disease (e.g., nursing home care and indirect costs) accounts for the largest proportion of the total annual economic burden of stroke.
The total cost of TIA in Ireland was approximately €11.1 million in 2007.
Sincere thanks to the Irish Heart Foundation (IHF), the IHF Council on Stroke, and to colleagues from the North Dublin Population Stroke Study, the Department of Pharmacology & Therapeutics, Trinity Centre, St James's Hospital, to Professor David Whitford (RCSI-MUB Bahrain) and Professor Ronan Conroy (RCSI), and to many other health service personnel for their support and contribution to this study. Any mention or reporting of data from this article should be attributed to Age and Ageing.
Gabby Fletcher | EurekAlert!
How to design city streets more fairly
18.05.2020 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH
Insects: Largest study to date confirms declines on land, but finds recoveries in freshwater – Highly variable trends
24.04.2020 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering